Cumulative Perinatal Steroids: Child Development of Preterm Infants

Journal of Pediatric Nursing

Volumn 23, Issue 3, 2008, Pages 201-214

  Purdy, Isabell B ^a   Wiley, Dorothy J ^a   Smith, Lynne M ^a   Howes, Carollee ^a   Gawlinski, Anna ^a   Robbins, Wendy ^a   Badr, Lina K ^a  

^a UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

Dexamethasone; Neurodevelopment; Perinatal steroids; Preterm infants

Indexed keywords

DEXAMETHASONE; GLUCOCORTICOID;

ADULT; ANALYSIS OF VARIANCE; ANTHROPOMETRY; ARTICLE; CHEMICALLY INDUCED DISORDER; CHI SQUARE DISTRIBUTION; CHILD; DEVELOPMENTAL DISORDER; FEMALE; HOSPITALIZATION; HUMAN; MALE; MORBIDITY; NEWBORN; NEWBORN INTENSIVE CARE; PARENT; PERINATAL CARE; PREGNANCY; PREMATURE LABOR; PROSPECTIVE STUDY; PSYCHOLOGICAL ASPECT; QUESTIONNAIRE; REGRESSION ANALYSIS; RISK FACTOR; TREATMENT OUTCOME;

ADULT; ANALYSIS OF VARIANCE; ANTHROPOMETRY; CHI-SQUARE DISTRIBUTION; CHILD; DEVELOPMENTAL DISABILITIES; DEXAMETHASONE; FEMALE; GLUCOCORTICOIDS; HUMANS; INFANT, NEWBORN; INTENSIVE CARE, NEONATAL; MALE; MORBIDITY; OBSTETRIC LABOR, PREMATURE; PARENTS; PERINATAL CARE; PREGNANCY; PROSPECTIVE STUDIES; QUESTIONNAIRES; REGRESSION ANALYSIS; RISK FACTORS; SEVERITY OF ILLNESS INDEX; TREATMENT OUTCOME;

EID: 43449105019     PISSN: 08825963     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.pedn.2007.09.006     Document Type: Article

References (63)

1. Als H. A synactive model of neonatal behavioral organization: Framework for the assessment of neurobehavioral development in the premature infant and for support of infants and parents in the neonatal intensive care environment. In: Sweeney J.K. (Ed). The high-risk neonate: Developmental therapy perspectives, physical and occupational therapy in pediatrics (1986) 3-55
2. Als H., Lester H., and Brazelton B. Dynamics of the behavioral organization of the premature infant: A theoretical perspective. In: Field T.M., Sostek A.M., and S.Goldberg H.H. (Eds). Infants born at risk (1979), Spectrum, New York
3. American Academy of Pediatrics, Committee on Fetus and Newborn. Postnatal corticosteroids to treat or prevent chronic lung disease in preterm infants. Pediatrics 109 (2002) 330-340
4. Ballard P., and Ballard R. Scientific basis and therapeutic regimens for use of antenatal glucocorticoids. American Journal of Obstetrics and Gynecology 181 (1995) 709-717
5. Barrington K., Denson-Lino J., Bloch R., and Finer N. Sequential analysis for quality control in the neonatal intensive care unit. Journal of Pediatrics 139 (2001) 778-784
6. Barrington K.J. The adverse neurodevelopmental effects of postnatal steroids in the preterm infant: A systematic review of RCTs. BMC Pediatrics 1 (2001) 1
7. Barrington K.J. Hazards of systemic steroids for ventilator-dependent preterm infants: What would a parent want?. Journal of Canadian Medical Association 165 (2001) 33-34
8. Barrington K.J. Postnatal steroids and neurodevelopmental outcomes: A problem in the making. Pediatrics 107 (2001) 1425-1426
9. Beliakov V.A., Kashin A.V., and Popova I.V. Impact of the type of feeding on children's physical development. Gigiena in Sanitaria (2003) 48-50 [Abstract]
10. Benesova O., and Pavlik A. Perinatal treatment with glucocorticoids and the risk of maldevelopment of the brain. Neuropharmacology 28 (1989) 89-97
11. Bhuta T., and Ohlsson A. Systematic review and meta-analysis of early postnatal dexamethasone for prevention of chronic lung disease. Archives of Disease in Childhood, Fetal and Neonatal Edition 79 (1998) F26-F33
12. Bos A., Dibiasi J., Tiessen A., and Bergman K. Treating preterm infants at risk for chronic lung disease with dexamethasone leads to an impaired quality of general movements. Biology of the Neonate 82 (2002) 155-158
13. Bührer C., Grimmer I., Metze B., and Obladen M. The CRIB (Clinical Risk Index for Babies) score and neurodevelopmental impairment at one year corrected age in very low birth weight infants. Intensive Care Medicine 26 (2000) 325-329
14. Coe C., and Lubach G. Prenatal influences on neuroimmune set points in infancy. Annals of the New York Academy of Sciences 917 (2000) 468-477
15. Dobbing J., and Sands J. Head circumference, biparietal diameter and brain growth in fetal and postnatal life. Early Human Development 2 (1978) 81-87
16. Doyle L., and Davis P. Postnatal corticosteroids in preterm infants: Systematic review of effects on mortality and motor function. Journal of Paediatrics and Child Health 36 (2000) 101-107
17. Doyle L., Ford G., Rickards A., Kelly A., Davis N., and Callanan C. Antenatal corticosteriods and outcome at 14 years of age in children with birth weight less than 1501 grams. Pediatrics 106 (2000) e2 (Abstract)
18. Esplin M., Fausett M., and Smith S. Multiple courses of antenatal steroids are associated with delay in long-term psychomotor development in children with birth weights ≤1500 grams. American Journal of Obstetrics and Gynecology 182 (2000) S24
19. Feldman R., and Eidelman A. Direct and indirect effects of breast milk on neurobehavioral and cognitive development of premature infants. Developmental Psychobiology 43 (2003) 109-119
20. Flaskerud J., and Winslow B. Conceptualizing vulnerable populations health related research. Nursing Research 47 (1998) 69-77
21. Fowlie P., Gould C., Tarnow-Mordi W., and Strang D. Measurement properties of CRIB (Clinical Risk Index for Babies)-Validity beyond the first 12 h of life, reliability and responsiveness. Early Human Development 47 (1997) 214-215
22. French N., Hagan R., Evans S., Godfrey M., and Newnham J. Repeated antenatal corticosteroids: Size at birth and subsequent development. American Journal of Obstetrics and Gynecology 180 (1999) 114-121
23. Gagliardi L., Cavazza A., Brunelli A., Battaglioli M., Merzzi D., Tandoi F., et al. Assessing mortality risk in very low birthweight infants: A comparison of CRIB, CRIB-II, and SNAPPE-II. Archives of Disease in Childhood, Fetal and Neonatal Edition 89 (2004) F419-F422
24. Guo S., Roche A., Chumlea W., Casey P.H., and Moore W.M. Growth in weight, recumbent length, and head circumference for preterm low-birthweight infants during the first three years of life using gestation-adjusted ages. Early Human Development 47 (1997) 305-325
25. Hack M., Breslau N., Weissman B., Aram D., Klein N., and Borawski E. Effect of very low birth weight and subnormal head size on cognitive abilities at school age. New England Journal of Medicine 325 (1991) 231-237
26. Hack M., Flannery D., Schluchter M., Cartar L., and Klein N. Outcomes of young adulthood for very-low-birth-weight infants. New England Journal of Medicine 346 (2002) 149-157
27. Hack M., Taylor H., Klein N., and Mercuri-Minich N. Functional limitations and special health care needs of 10- to 14-year-old children weighing less than 750 grams at birth. Pediatrics 106 (2000) 554-560
28. Halliday H.L., and Ehrenkranz R.A. Delayed (>3 weeks) postnatal corticosteroids for chronic lung disease in preterm infants. Cochrane Database of Systematic Reviews (2001) 2
29. Halliday H.L., and Ehrenkranz R.A. Early postnatal (<96 hours) corticosteroids for preventing chronic lung disease in preterm infants. Cochrane Database of Systematic Reviews (2001) 1
30. Horbar J., Badger G., Carpenter J., Fanaroff A., Kilpatrick S., and LaCorte M. Trends in mortality and morbidity for very low birth weight infants, 1991-1999. Pediatrics 110 (2002) 143-151
31. Huang C., Dunlap S., and Harper C. Effect of exogenous corticosteroids on the developing central nervous system. Obstetrical & Gynecological Survey 54 (1999) 336-342
32. Jobe A., and Ikegami M. Beyond the NIH Consensus Conference for antenatal glucocorticoids. Neonatal Respiratory Diseases 10 (2000) 1-8
33. Jobe A., Wada N., Berry L., Ikegami M., and Ervin M. Single and repetitive maternal glucocorticoid exposures reduce fetal growth in sheep. American Journal of Obstetrics and Gynecology 178 (1998) 880-885
34. Kopelman A., Moise A., Holbert D., and Hegemier S. A single very early dexamethasone dose improves respiratory and cardiovascular adaptation in preterm infants. Journal of Pediatrics 135 (1999) 345-350
35. Liggins G. Premature delivery of foetal lambs infused with glucocorticoids. Journal of Endocrinology 45 (1969) 515-523
36. Liggins G., and Howie R. A controlled trial of antepartum glucocorticoid treatment for prevention of the respiratory distress syndrome in premature infants. Pediatrics 50 (1972) 515-525
37. Lubchenco L.O., Hansmans C., and Boyd E. Intrauterine growth in length and head circumference as estimated from live births at gestational ages from 26 to 42 weeks. Pediatrics 37 (1966) 403-408
38. Matthews S.G. Antenatal glucocorticoids and programming of the developing CNS. Pediatric Research 47 (2000) 291-300
39. Matthews S.G. Antenatal glucocorticoids and the developing brain: Mechanisms of action. Seminars in Neonatology 6 (2001) 309-317
40. Meaney M.J., and Stewart J. Neonatal-androgens influence the social play of prepubescent rats. Hormones and Behavior 15 (1981) 197-213
41. Mercer J., and Lewis J. Adaptive Behavior Inventory for Children (1978), The Psychological Corporation, New York
42. Murphy B., Inder T., Huppi P., Warfield S., Zientara G., Kikinis R., et al. Impaired cerebral cortical gray matter growth after treatment with dexamethasone for neonatal chronic lung disease. Pediatrics 10 (2001) 217-221
43. National Institutes of Health. Report of the consensus development conference on antenatal corticosteroids revisited: Repeat courses (2000), National Institute of Child Health and Human Development, Bethesda, MD
44. National Institutes of Health Consensus Development Conference Statement. Effect of corticosteroids for fetal maturation on perinatal outcomes, February 28-March 2, 1994. American Journal of Obstetrics and Gynecology 173 (1994) 246-252
45. O'Shea T., and Doyle L. Perinatal glucocorticoid therapy and neurodevelopmental outcome: An epidemiologic perspective. Seminars in Neonatology 6 (2001) 293-307
46. Peabody J. Interpreting risks of steroids for preterm infants. Journal of Pediatrics 137 (2000) 590-592
47. Perlman J.M. Neurobehavioral deficits in premature graduates of intensive care-Potential medical and neonatal environmental risk factors. Pediatrics 108 (2001) 1339-1348
48. Richardson D., Tarnow-Mordi W., and Escobar G. Neonatal risk scoring systems. Can they predict mortality and morbidity?. Clinics in Perinatology 25 (1998) 591-611
49. Rosenbaum P., Saigal S., Szatmari P., and Hoult L. Vineland Adaptive Behavior Scales as a summary of functional outcome of extremely low birthweight children. Developmental Medicine and Child Neurology 37 (1995) 577-586
50. SAS System for Windows, Release 8.02. (1999-2001). North Carolina SAS Institute.
51. Sherry B., Zuguo M., Grummer-Strawn L., and Dietz W. Evaluation of and recommendations for growth references for very low birth weight (≤1500 grams) infants in the United States. Pediatrics 111 (2003) 750-758
52. Shinwell E., Karplus M., Reich D., Weintraub Z., Blazer S., Bader D., et al. Early postnatal dexamethasone treatment and increased incidence of cerebral palsy. Archives of Disease in Childhood, Fetal and Neonatal Edition 83 (2000) F177-F181
53. Shonkoff J.P., and Phillips D.A. From neurons to neighborhoods: The science of early childhood development (2000), National Research Council, Institutes of Medicine, Washington, DC
54. Smith L., Qureshi N., and Chao C. Effects of single and multiple courses of antenatal glucocorticoids in preterm newborns less than 30 weeks' gestation. Journal of Maternal-Fetal Medicine 9 (2000) 131-135
55. Sparrow S., Balla D., and Cicchetti D. Vineland Adaptive Behavior Scales survey form manual (1984), American Guidance Incorporated, Minnesota
56. Spreen O., Risser A., and Edgell D. Developmental neuropsychology (1995), Oxford University Press, New York
57. Stark A., Carlo W., Tyson J., Papile L., Wright L., Shankaran S., et al. Adverse effects of early dexamethasone in extremely-low-birth-weight infants. National Institute of Child Health and Human Development Neonatal Research Network. New England Journal of Medicine 344 (2001) 95-101
58. STATA Statistical Software System for Windows, Release 8. (1985-2003). Texas: STATA Corporation.
59. Vineland Adaptive Behavior Scales. (2001). American Guidance Services.
60. Walsh M., Yao Q., Horbar J., Carpenter J., Lee S., and Ohlsson A. Pediatrics 118 (2006) 1328-1335
61. Weichsel M. The therapeutic use of glucocorticoid hormones in the perinatal period: Potential neurologic hazards. Annals of Neurology 2 (1977) 364-366
62. Weiss A., and Van Haren M. What pediatricians should know about normal language development: Ensuring cultural differences are not diagnosed as disorders. Pediatric Annals 32 (2003) 446-452
63. Yeh T., Lin Y., Lin H., Huang C., Hsieh W., Lin C., et al. Outcomes at school age after postnatal dexamethasone therapy for lung disease of prematurity. New England Journal of Medicine 350 (2004) 1304-1313